In Phase C, contributors will receive ABBV-744 and oral navitoclax. In Phase D, members will obtain ABBV-744 and ruxolitinib. Individuals will obtain treatment until condition progression or perhaps the members are not able to tolerate the study drugs. - Participant consumed grapefruit or grapefruit products and solutions within 3 days https://isabbv-744effectiveforhem57913.blogpixi.com/32367499/considerations-to-know-about-is-abbv-744-effective-for-hematologic-cancers